Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) Return on Invested Capital (2023 - 2025)

Historic Return on Invested Capital for GeneDx Holdings (WGS) over the last 4 years, with Q3 2025 value amounting to 0.02%.

  • GeneDx Holdings' Return on Invested Capital rose 2500.0% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year increase of 2500.0%. This contributed to the annual value of 0.1% for FY2024, which is 6300.0% up from last year.
  • Latest data reveals that GeneDx Holdings reported Return on Invested Capital of 0.02% as of Q3 2025, which was up 2500.0% from 0.02% recorded in Q2 2025.
  • GeneDx Holdings' Return on Invested Capital's 5-year high stood at 0.02% during Q3 2025, with a 5-year trough of 1.97% in Q1 2023.
  • Its 4-year average for Return on Invested Capital is 0.72%, with a median of 0.59% in 2022.
  • In the last 5 years, GeneDx Holdings' Return on Invested Capital crashed by -10600bps in 2023 and then surged by 14800bps in 2024.
  • Over the past 4 years, GeneDx Holdings' Return on Invested Capital (Quarter) stood at 1.47% in 2022, then soared by 51bps to 0.73% in 2023, then skyrocketed by 88bps to 0.09% in 2024, then surged by 127bps to 0.02% in 2025.
  • Its last three reported values are 0.02% in Q3 2025, 0.02% for Q2 2025, and 0.05% during Q1 2025.